- New research report querying
U.S. surgeons and medical professionals on AR smart glasses usage,
sentiment and preferences in surgical settings delivers a bullish
outlook
- Use of AR smart glasses expected to
transform surgical practices, enhancing precision, efficiency, and
patient outcomes
ROCHESTER, N.Y., June 20,
2023 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:
VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart
Glasses and Augmented Reality (AR) technology and products, today
released a new report which points to expanding medical use of AR
smart glasses by quantifying the increasing interest among U.S.
surgeons in adopting such devices for their practices. Conducted by
third-party research firm Censuswide, the report features insight
from over 500 surgeons across the United
States and highlights the immense potential of AR wearables
within the operating room and beyond.
Specific benefits highlighted by the study include:
- 50% of surgeons have already been exposed to some form of
training with AR smart glasses and admit its potential benefits
over traditional methods.
- 49% agreed that AR smart glasses could effectively reduce
complications and fatalities in operating rooms caused by human
error.
- 44% of surgeons emphasized the ability of AR smart glasses to
provide access to in-depth information within their field of view,
including 3D anatomical images, models, real-time medical
references, and patient information.
- 41% acknowledged the potential of these smart glasses in
creating lower-risk surgical environments by minimizing unnecessary
entry and exit from the operating room.
- 30% recognized the potential cost reduction in surgical
equipment and staff.
- 28% acknowledged the benefits of collaborating with remote
clinical teams and accessing surgical care worldwide.
- 26% expressed that AR smart glasses could significantly
expedite surgical operation preparation times.
"We are thrilled to witness the increasing interest among U.S.
surgeons in adopting AR smart glasses as a hands-free solution for
surgical procedures, a market for which our family of products is
ideally suited," stated Paul
Travers, President and CEO of Vuzix. "This report reveals
the transformative power of AR technology can have in improving
patient outcomes. These results are achieved by providing real-time
information, remote assistance, and advanced visualization
capabilities. Further the report also speaks to the sizable cost
saving potential for medical institutions by helping them with
minimizing human error, reducing risk factors, and economizing
surgical resources. At Vuzix, we remain committed to developing
cutting-edge AR solutions and establishing additional partnerships
that will further empower surgeons and enhance the future of
healthcare."
To learn more about the findings from the Vuzix 2023 AR in
Surgical Settings Report, including further analysis, please refer
to Appendix A in this release and visit our AR in medicine survey
summary page.
About Vuzix Corporation
Vuzix is a leading designer, manufacturer and marketer of Smart
Glasses and Augmented Reality (AR) technologies and products for
the enterprise, medical, defense and consumer markets. The
Company's products include head-mounted smart personal display and
wearable computing devices that offer users a portable high-quality
viewing experience, provide solutions for mobility, wearable
displays and augmented reality, as well OEM waveguide optical
components and display engines. Vuzix holds more than 300 patents
and patents pending and numerous IP licenses in the fields of
optics, head-mounted displays, and augmented reality Video Eyewear
field. Moviynt, an SAP Certified ERP SaaS logistics solution
provider, is a Vuzix wholly owned subsidiary. The Company has won
Consumer Electronics Show (or CES) awards for innovation for the
years 2005 to 2023 and several wireless technology innovation
awards among others. Founded in 1997, Vuzix is a public company
(NASDAQ: VUZI) with offices in: Rochester, NY; Oxford, UK; Munich,
Germany; and Kyoto and
Tokyo, Japan. For more
information, visit the Vuzix website, Twitter and
Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are
"forward-looking statements" within the meaning of the Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws. Forward-looking statements contained in this release relate
to the benefits of Vuzix Smart Glasses in medicine, their
capabilities and among other things the Company's leadership in the
Smart Glasses and AR display industry. They are generally
identified by words such as "believes," "may," "expects,"
"anticipates," "should" and similar expressions. Readers should not
place undue reliance on such forward-looking statements, which are
based upon the Company's beliefs and assumptions as of the date of
this release. The Company's actual results could differ materially
due to risk factors and other items described in more detail in the
"Risk Factors" section of the Company's Annual Reports and MD&A
filed with the United States Securities and Exchange Commission and
applicable Canadian securities regulators (copies of which may be
obtained at www.sedar.com or www.sec.gov). Subsequent events and
developments may cause these forward-looking statements to change.
The Company specifically disclaims any obligation or intention to
update or revise these forward-looking statements as a result of
changed events or circumstances that occur after the date of this
release, except as required by applicable law.
Media Relations Contact
Jessica Starman
jessica@elev8newmedia.com
888-461-2233
Media and Investor Relations Contact:
Ed McGregor, Director of Investor
Relations
Vuzix Corporation
ed_mcgregor@vuzix.com
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
APPENDIX A – Report Findings
This report sheds significant light on the increasing interest
in and adoption of AR smart glasses among surgeons. The report's
findings indicate a significant appetite for incorporating these
advanced devices into surgical workflows. Currently, 25% of
surgeons have already integrated AR smart glasses into their
practice, while an additional 31% are actively considering their
utilization. Impressively, 19% of surgeons have previously tried AR
smart glasses and found them helpful in their procedures. A small
percentage (12%) reported less satisfactory experiences and only
11% have yet to explore the benefits of AR smart glasses.
The report also examines regional variances in the familiarity
and usage of AR smart glasses among surgeons, emphasizing the
significance of regional dynamics in implementing AR technology in
surgical environments. Surgeons in the South displayed the highest
level of familiarity and adoption of AR smart glasses, with 27% of
respondents already incorporating these advanced devices into their
practice. Conversely, surgeons in the West reported a slightly
lower adoption rate, with 21% indicating familiarity and usage of
AR smart glasses.
Specialty-wise, Transplant Surgeons exhibited the highest level
of familiarity and interest in adopting AR smart glasses, with over
2 in 5 (41%) expressing enthusiasm for their use. Neurosurgeons
followed suit, with approximately one-third (34%) sharing the same
sentiment.
While age demographics had a limited impact on the adoption of
AR smart glasses, slight variations were observed among different
age groups. Surgeons aged 25-34 and 35-44 showed a higher
propensity (35% and 34% respectively) for considering the
incorporation of AR smart glasses compared to their counterparts
aged 45-54 (26%).
The study also explored surgeons' training experiences with AR
smart glasses, revealing that almost two-thirds (67%) of the
surveyed surgeons have received training in using these advanced
devices. Among this group, a quarter expressed their firm belief
that AR smart glasses represent the future of surgical education
(25%) and acknowledged their potential benefits over traditional
teaching methods (25%). It is evident that a significant portion of
surgeons recognizes the transformative potential of AR smart
glasses in shaping the future of surgical training.
Furthermore, the study highlighted the specific preferences and
perspectives of surgeons across different age groups. Among
surgeons aged 25-34, a notable 42% expressed their belief in the
value of "Training prospective surgeons and caregivers with a
see-what-I-see view," emphasizing the potential benefits this
approach holds. In comparison, 29% of surgeons aged 45-54 shared
the same view, indicating a slightly lower inclination towards this
training method.
When examining different specialties, Transplant Surgeons stood
out with a higher inclination towards being trained with AR smart
glasses and expressing their confidence in its future impact on
surgical education. Nearly 4 in 10 (39%) Transplant Surgeons held
this belief, while Neurosurgeons exhibited a slightly lower level
of conviction at 26%.
The research findings shed light on the significant benefits of
AR smart glasses in surgical practice, eliciting a positive
sentiment among surveyed surgeons. Nearly half of the respondents
(49%) agreed that AR smart glasses could effectively reduce
complications and fatalities in operating rooms caused by human
error. Additionally, 48% believed that these innovative glasses
have the potential to enhance surgeons' accuracy, speed, and
overall efficiency through features like remote assistance and
assistive software.
Age-related differences were observed in the perceived benefits.
Surgeons aged 25-34 exhibited a higher likelihood of recognizing
the advantages of AR smart glasses in accessing in-depth
information (55%), creating low-risk surgical environments (45%),
and training prospective surgeons (42%). In contrast, surgeons aged
45-54 showed slightly lower levels of recognition for these
benefits (40%, 38%, 29%).
Notably, there were specialty-specific variations as well.
Orthopedic Surgeons expressed the strongest belief (49%) in the
potential of AR smart glasses to create lower-risk surgical
environments. Neurosurgeons (58%) were more inclined to agree that
AR smart glasses have the potential to reduce complications and
deaths in operating rooms due to human error. Ophthalmic Surgeons
(43%) also shared a similar sentiment regarding the benefits of AR
smart glasses in improving surgical outcomes.
In addition to uncovering the positive sentiment towards AR
smart glasses, the research also explored the concerns expressed by
surveyed surgeons regarding their adoption in the operating room.
Foremost among these concerns is the comfort of smart glasses, with
a third of surgeons (33%) highlighting this as a top concern.
Following closely behind are interface challenges (29%), learning
curve (29%), and battery life (28%). Sensory overload (25%), cost
(24%), privacy (21%), and unreliable WiFi (19%) were also cited as
potential issues.
Report Methodology
Report findings were based on a comprehensive survey of 506
surgical professionals. Fieldwork was conducted between
May 3rd - May 5th, 2023. The figures
have been weighted and are representative of all U.S. adults aged
25 and above.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vuzix-releases-new-report-confirming-the-benefits-from-increasing-usage-and-interest-for-ar-smart-glasses-among-surgeons-301855335.html
SOURCE Vuzix Corporation